Palliative Care consultations and interventions including comprehensive symptom assessment and documentation of life sustaining treatment preferences will increase on Med E services for patients with advanced cancer by July 2016. PROBLEM Palliative care is not highly incorporated into the multidisciplinary care of incurable cancer patients at UNC. Only 22% had comprehensive symptom assessment and 32% documentation of life sustaining treatment preferences. ICU transfer and 30-day readmission rates are relatively high.
MEASURES
The primary outcome, treatment preferences, will increase from 32 to 48% and secondary outcomes, ICU transfers will decrease from 82/1000 to 65/1000, 30 day re-admissions will decrease from 22.4 to 18% and Hospice referrals will increase from 3 to 15%. The primary outcome will be tracked on a monthly basis in the medical record and the secondary outcomes tracked on a quarterly basis through the Cost Accounting Analysis database.
RISKS/BARRIERS
An unintended consequence may be to increase the resistance among patients and clinicians to engage with Palliative Care. Some oncology attending physicians will be resistive to palliative care because they see it as end of life care for people who are actively dying. STAKEHOLDERS Hematology/Oncology fellows, residents, and NP/PA staff and patients with advanced cancer and their families are the key clinical stakeholders. The nursing leadership and the interdisciplinary project team will provide interprofessional input on an ongoing basis through monthly meetings. The nursing supervisors will keep the team aware of patient and family perspectives and relay any feedback received during the project. The first team project meeting was held in June 2015. The team will meet on a monthly basis. A research assistant will be hired before the end of July. The chart review and root cause analysis begins in July along with the fellow and housestaff training. Quarterly collection of quality metrics are scheduled for October 2015, January 2016, April 2016, and July 2017. The final report and sustainability planning will begin at the end of June 2016.
SCOPE
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